Skip to main content
Top
Published in: European Child & Adolescent Psychiatry 2/2011

01-02-2011 | Review Article

Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry

Author: Celso Arango

Published in: European Child & Adolescent Psychiatry | Issue 2/2011

Login to get access

Abstract

The DSM-5 task force on schizophrenia and psychotic disorders have recently proposed to include attenuated psychotic symptoms syndrome as a disorder not currently listed in DSM-IV-TR, either in the main manual or in an Appendix for further research. One of the potential benefits of including this diagnosis in DSM-5 is to identify persons at high risk of developing psychotic disorders to prevent the appearance of these disorders or lead to disorders with a better prognosis. One of the challenges applying the criteria proposed to the pediatric population is the difficulty in defining “attenuated” in the same way and it is done with adults. The threshold for psychosis may be lower in children and, therefore, what is attenuated in adults may be fully present, although transient, in paediatric population. Other potential risks are a lower threshold for prescribing antipsychotics without clear evidence and whether the help-seeking behaviour criterion will be applied to the patients and/or the parents.
Literature
1.
go back to reference NIMH (2007) Transformative neurodevelopmental research in mental illness. Report of the national advisory mental health council’s workgroup NIMH (2007) Transformative neurodevelopmental research in mental illness. Report of the national advisory mental health council’s workgroup
4.
go back to reference Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkotter J (2010) Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull 36(1):182–191. doi:10.1093/schbul/sbn072 CrossRefPubMed Schultze-Lutter F, Ruhrmann S, Berning J, Maier W, Klosterkotter J (2010) Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state. Schizophr Bull 36(1):182–191. doi:10.​1093/​schbul/​sbn072 CrossRefPubMed
5.
go back to reference McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rossler A, Klosterkotter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR (2009) Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry 70(9):1206–1212. doi:10.4088/JCP.08r04472 CrossRefPubMed McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rossler A, Klosterkotter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR (2009) Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry 70(9):1206–1212. doi:10.​4088/​JCP.​08r04472 CrossRefPubMed
6.
go back to reference Phillips LJ, Nelson B, Yuen HP, Francey SM, Simmons M, Stanford C, Ross M, Kelly D, Baker K, Conus P, Amminger P, Trumpler F, Yun Y, Lim M, McNab C, Yung AR, McGorry PD (2009) Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics. Aust N Z J Psychiatry 43(9):818–829. doi:10.1080/00048670903107625 CrossRefPubMed Phillips LJ, Nelson B, Yuen HP, Francey SM, Simmons M, Stanford C, Ross M, Kelly D, Baker K, Conus P, Amminger P, Trumpler F, Yun Y, Lim M, McNab C, Yung AR, McGorry PD (2009) Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics. Aust N Z J Psychiatry 43(9):818–829. doi:10.​1080/​0004867090310762​5 CrossRefPubMed
7.
go back to reference McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A (2006) Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 163(5):790–799. doi:163/5/790[pii]10.1176/appi.ajp.163.5.790 CrossRefPubMed McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A (2006) Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 163(5):790–799. doi:163/​5/​790[pii]10.​1176/​appi.​ajp.​163.​5.​790 CrossRefPubMed
10.
go back to reference Freeman LN, Poznanski EO, Grossman JA, Buchsbaum YY, Banegas ME (1985) Psychotic and depressed children: a new entity. J Am Acad Child Psychiatry 24(1):95–102CrossRefPubMed Freeman LN, Poznanski EO, Grossman JA, Buchsbaum YY, Banegas ME (1985) Psychotic and depressed children: a new entity. J Am Acad Child Psychiatry 24(1):95–102CrossRefPubMed
12.
go back to reference van Os J, Hanssen M, Bijl RV, Vollebergh W (2001) Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch Gen Psychiatry 58(7):663–668. doi:yoa20258[pii] CrossRefPubMed van Os J, Hanssen M, Bijl RV, Vollebergh W (2001) Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch Gen Psychiatry 58(7):663–668. doi:yoa20258[pii] CrossRefPubMed
15.
go back to reference Horwood J, Salvi G, Thomas K, Duffy L, Gunnell D, Hollis C, Lewis G, Menezes P, Thompson A, Wolke D, Zammit S, Harrison G (2008) Iq and non-clinical psychotic symptoms in 12-year-olds: results from the alspac birth cohort. Br J Psychiatry 193(3):185–191. doi:10.1192/bjp.bp.108.051904 CrossRefPubMed Horwood J, Salvi G, Thomas K, Duffy L, Gunnell D, Hollis C, Lewis G, Menezes P, Thompson A, Wolke D, Zammit S, Harrison G (2008) Iq and non-clinical psychotic symptoms in 12-year-olds: results from the alspac birth cohort. Br J Psychiatry 193(3):185–191. doi:10.​1192/​bjp.​bp.​108.​051904 CrossRefPubMed
18.
go back to reference Arango C, Robles O, Parellada M, Fraguas D, Ruiz-Sancho A, Medina O, Zabala A, Bombin I, Moreno D (2009) Olanzapine compared to quetiapine in adolescents with a first psychotic episode. Eur Child Adolesc Psychiatry 18(7):418–428. doi:10.1007/s00787-009-0749-5 CrossRefPubMed Arango C, Robles O, Parellada M, Fraguas D, Ruiz-Sancho A, Medina O, Zabala A, Bombin I, Moreno D (2009) Olanzapine compared to quetiapine in adolescents with a first psychotic episode. Eur Child Adolesc Psychiatry 18(7):418–428. doi:10.​1007/​s00787-009-0749-5 CrossRefPubMed
Metadata
Title
Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry
Author
Celso Arango
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
European Child & Adolescent Psychiatry / Issue 2/2011
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-010-0144-2

Other articles of this Issue 2/2011

European Child & Adolescent Psychiatry 2/2011 Go to the issue

Original Contribution

Non-suicidal self-injury